Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified key prognostic genes in colon cancer using a new integrated database. This tool aids in discovering biomarkers and therapeutic targets for improved patient stratification and treatment strategies.
Area Of Science
- Oncology
- Genomics
- Bioinformatics
Background
- Identifying prognostic genes in solid tumors is crucial for patient stratification and discovering new therapeutic targets.
- Previous analyses ranked survival-associated genes in various solid tumors.
Purpose Of The Study
- To expand survival gene analysis to include colon cancer specimens with transcriptomic and clinical data.
- To develop and demonstrate a colon cancer analysis subsystem within an existing Kaplan-Meier plotter.
Main Methods
- A Gene Expression Omnibus search identified relevant datasets with clinical and gene expression data.
- A combined colon cancer database (2,137 samples, 17 cohorts) was integrated into a Kaplan-Meier plotter.
- Uni- and multivariate Cox regression analyses identified genes linked to overall and relapse-free survival.
Main Results
- The analysis identified significant genes associated with relapse-free survival in colon cancer, including RBPMS, TIMP1, and COL4A2.
- For stage II colon cancer, CSF1R, FLNA, and TPBG were identified as strong predictors of shorter survival.
- A new integrated database and analysis subsystem for colon cancer were successfully developed and demonstrated.
Conclusions
- A novel integrated database and analysis tool for colon cancer have been established.
- The developed platform facilitates the identification and prioritization of potential biomarkers and therapeutic targets.
- This resource has broad applicability for biomarker discovery in multiple solid tumors.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...